Consolidated Cash Flow Statement

30 KB EXCEL

 
€ million Note 2017 2016
Profit after tax 2,610 1,633
Depreciation / amortization / impairment losses / reversals of impairments 1,758 1,934
Changes in inventories – 184 23
Changes in trade accounts receivable – 221 – 73
Changes in trade accounts payable 234 76
Changes in provisions 103 – 51
Changes in other assets and liabilities – 1,256 – 587
Neutralization of gains/losses on disposal of assets – 346 – 451
Other non-cash income and expenses – 3 14
Net cash flows from operating activities ➞ 34 2,696 2,518
thereof: from discontinued operations
 
Payments for investments in intangible assets – 392 – 132
Payments from the disposal of intangible assets 4 2
Payments for investments in property, plant and equipment – 919 – 716
Payments from the disposal of property, plant and equipment 44 21
Payments for investments in financial assets – 219 – 344
Payments for acquisitions less acquired cash and cash equivalents – 17 – 156
Payments from the disposal of other financial assets 185 457
Payments from divestments less transferred cash and cash equivalents 11 5
Payments from other divestments – 3
Payments from divestment of assets held for sale 156 364
Net cash flows from investing activities ➞ 35 – 1,147 – 503
thereof: from discontinued operations 24w
 
Dividend payments to shareholders of Merck KGaA, Darmstadt, Germany – 155 – 136
Dividend payments to non-controlling interests – 4 – 3
Dividend payments to E. Merck KG, Darmstadt, Germany – 466 – 461
Payments from new borrowings of financial liabilities from E. Merck KG, Darmstadt, Germany 349 881
Repayments of financial liabilities to E. Merck KG, Darmstadt, Germany – 314 – 729
Repayment of bonds – 932 – 272
Payments from new borrowings of other current and non-current financial liabilities 147 236
Repayments of other current and non-current financial liabilities – 496 – 1,424
Net cash flows from financing activities ➞ 36 – 1,870 – 1,908
thereof: from discontinued operations
 
Changes in cash and cash equivalents – 320 107
Changes in cash and cash equivalents due to currency translation – 30 8
Cash and cash equivalents as of January 1 939 832
Changes in cash and cash equivalents due to changes in scope of consolidation – 8
Cash and cash equivalents as of December 31 589 939
Plus cash and cash equivalents included in assets held for sale
Cash and cash equivalents as of December 31 (consolidated balance sheet) ➞ 24 589 939